Floating Button
Home Capital Broker's Calls

Why CLCT is a 'buy' despite its weak FY2020 results

Jeffrey Tan
Jeffrey Tan • 2 min read
Why CLCT is a 'buy' despite its weak FY2020 results
DBS believes that CLCT has “compelling value for a morphing China behemoth”.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts have continued their optimism for CapitaLand China Trust (CLCT), formerly known as CapitaLand Retail China Trust (CRCT), despite CLCT’s weak FY2020 results ended Dec 31.

DBS Group Research has maintained its “buy” call for the trust albeit with a lower target price of $1.55 from $1.70 previously.

OCBC Investment Research, too, has a “buy” rating for the trust with a higher fair value of $1.58 from $1.35 previously.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.